Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Greater Good Health Welcomes Michael Grover as Chief Financial Officer
Greater Good Health, the company redefining value-based care through the first primary care model centered […]
Concord Health Partners Expands Senior Team & Opens Nashville Office
Concord Health Partners (“Concord” or the “Firm”), a healthcare focused investment firm, today announced that […]
M2GEN Expands World-Class Executive Leadership Team Appoints Melissa Honour, MPH, as Chief Product Officer
M2GEN, a bioinformatics company accelerating discoveries in oncology research through industry-leading data and analytics, today announced […]
Centauri Therapeutics Strengthens Senior Leadership Team With Three Key Appointments
Centauri Therapeutics Limited (Centauri), an immunotherapy company focused on the treatment of infectious diseases, today […]
Concord Health Partners Adds Healthcare Veteran Brian Gragnolati as Executive Partner
Concord Health Partners (“Concord” or the “Firm”), a healthcare focused investment firm, today announced that […]
Nosopharm Welcomes New Members To Supervisory Board
Nosopharm, specialized in exploring unconventional sources of antibiotics to discover new drugs to fight antimicrobial resistance, […]
CVS Health Names Tilak Mandadi Executive Vice President and Chief Data, Digital and Technology Officer
CVS Health (NYSE: CVS) has appointed Tilak Mandadi as Executive Vice President and to the newly created role […]
Nanoscope Therapeutics Appoints Michael Marquez as Chief Financial Officer
Nanoscope Therapeutics, Inc., a clinical-stage biotechnology company developing gene therapies to treat retinal degenerative diseases, […]
Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer
Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable […]
Breakthrough Radiology AI Provider Annalise.ai Appoints Proven Global Healthcare Leader as CEO, Officially Launches US Team Following FDA Clearances
annalise.ai, the global radiology AI company with rapidly growing presence in Asia- Pacific, Europe and the United Kingdom, today […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more